Lymphocyte toxicity assay: A tool to assess trimethoprim-sulfamethoxazole hypersensitivity syndrome reactions in human immunodeficiency virus-infected individuals.

被引:0
|
作者
Neuman, M [1 ]
Malkiewicz, I [1 ]
Phillips, E [1 ]
Rachlis, A [1 ]
Yeung, E [1 ]
Ong, D [1 ]
Shear, NH [1 ]
机构
[1] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1128
引用
收藏
页码:454A / 454A
页数:1
相关论文
共 50 条
  • [31] Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals
    Neuman, MG
    Malkiewicz, IM
    Phillips, EJ
    Rachlis, AR
    Ong, D
    Yeung, E
    Shear, NH
    THERAPEUTIC DRUG MONITORING, 2002, 24 (06) : 728 - 736
  • [34] Plasmodium falciparum Dihydrofolate Reductase and Dihyropteroate Synthase Mutations and the Use of Trimethoprim-Sulfamethoxazole Prophylaxis among Persons Infected with Human Immunodeficiency Virus
    Malamba, Samuel
    Sandison, Taylor
    Lule, John
    Reingold, Arthur
    Walker, Jordan
    Dorsey, Grant
    Mermin, Jonathan
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 82 (05) : 766 - 771
  • [35] PROLONGED ISOLATED FEVER DUE TO ATTENUATED EXTRACEREBRAL TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS WHO ARE RECEIVING TRIMETHOPRIM-SULFAMETHOXAZOLE AS PROPHYLAXIS
    ZYLBERBERG, H
    ROBERT, F
    LEGAL, FA
    DUPOUYCAMET, J
    ZYLBERBERG, L
    VIARD, JP
    CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) : 680 - 681
  • [36] Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study
    Nakashima, Kei
    Aoshima, Masahiro
    Nakashita, Tamao
    Hara, Masahiko
    Otsuki, Ayumu
    Noma, Satoshi
    Misawa, Masafumi
    Otsuka, Yoshihito
    Motojima, Shinji
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 810 - 820
  • [37] EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    SCHNEIDER, MME
    NIELSEN, TL
    NELSING, S
    HOEPELMAN, AIM
    SCHATTENKERK, JKME
    VANDERGRAAF, Y
    KOLSTERS, AFP
    BORLEFFS, JCC
    DANNER, SA
    VANLEEUWEN, R
    FRISSEN, JPHJ
    WEIGEL, HM
    VANDERENDE, IME
    SPRENGER, HG
    KAUFFMANN, RH
    KROON, F
    MEENHORST, PL
    TENNAPEL, CHH
    SCHREIJ, G
    TENKATE, RW
    JUTTMANN, JR
    KOOPMANS, PP
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (06) : 1632 - 1636
  • [38] A MANUAL BEAD ASSAY FOR THE DETERMINATION OF ABSOLUTE CD4(+) AND CD8(+) LYMPHOCYTE COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS
    CARELLA, AV
    MOSS, MW
    PROVOST, V
    QUINN, TC
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) : 623 - 625
  • [39] Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ
    Leoung, GS
    Stanford, JF
    Giordano, MF
    Stein, A
    Torres, RA
    Giffen, CA
    Wesley, M
    Sarracco, T
    Cooper, EC
    Dratter, V
    Smith, JJ
    Frost, KR
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) : 992 - 997
  • [40] Disseminated histoplasmosis:: A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals
    Tobón, AM
    Agudelo, CA
    Rosero, DS
    Ochoa, JE
    De Bedout, C
    Zuluaga, A
    Arango, M
    Cano, LE
    Sampedro, J
    Restrepo, A
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (03) : 576 - 582